Catalyst Wire Dossier Catalyst Wire Dossier

Ubrogepant

ubrogepant · AbbVie
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Ubrogepant, covering 2019-01-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

See pricing